NEGATIVE TRANSCRIPTIONAL REGULATION OF HUMAN INTERLEUKIN-2 (IL-2) GENE BY GLUCOCORTICOIDS THROUGH INTERFERENCE WITH NUCLEAR TRANSCRIPTION FACTORS AP-1 AND NF-AT
F. Paliogianni et al., NEGATIVE TRANSCRIPTIONAL REGULATION OF HUMAN INTERLEUKIN-2 (IL-2) GENE BY GLUCOCORTICOIDS THROUGH INTERFERENCE WITH NUCLEAR TRANSCRIPTION FACTORS AP-1 AND NF-AT, The Journal of clinical investigation, 91(4), 1993, pp. 1481-1489
IL-2 gene transcription is affected by several nuclear proteins. We as
ked whether dexamethasone (Dex) and cyclosporin A (CsA) inhibit IL-2 g
ene transcription by interfering with the activity of nuclear proteins
that bind to the IL-2 promoter. Nuclear extracts from primary human T
lymphocytes were analyzed by electrophoretic DNA mobility shift assay
s. Both Dex and CsA inhibited the binding of transcription factors AP-
1 and NF-AT, but not of NF-kB and OCT-1/OAF, to their corresponding si
tes on the IL-2 gene promoter. To correlate changes in nuclear factor
binding in vitro with transcriptional activity in vivo and define the
structural requirements for IL-2 promoter repression, we used transien
t DNA transfections. Jurkat cells were transfected with plasmids conta
ining either the intact IL-2 promoter or its AP-1, NF-AT, and NF-kB mo
tifs. Dex inhibited the IL-2 promoter and the AP-1, but not the NF-AT
and NF-kB plasmids. In contrast, CsA inhibited the IL-2 promoter and t
he NF-AT, but not the AP-1 and NF-kB plasmids. These results suggest t
hat in human T lymphocytes both Dex and CsA inhibited IL-2 gene transc
ription through interference with transcription factors AP-1 and NF-AT
. We propose that, while maximum inhibition may involve interaction wi
th both transcription factors, AP-1 is the primary target of Dex.